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Abstract
Background: Non-Hodgkin’s lymphomas (NHLs) are a heterogenous group of malignant tumors developing from the lymphoid tissue and having 
a wide range of clinical manifestations and varied evolution and prognosis.
Material and methods: We have studied the clinical peculiarities of 228 patients of different age groups with NHLs and a primary involvement of 
lymph nodes.
Results: The frequency of the lymph nodes primary involvement has constituted 37.6%.  It has been established that NHLs most frequently had their 
primary onset in the peripheral lymph nodes (61.8%), less frequently – in the abdominal (23.3%) and mediastinal (14.9%) ones.  NHLs most frequently 
begin their development in the peripheral lymph nodes, first in patients over 60 years old (84.6%), in the abdominal lymph nodes – in children (57.2%), 
in the mediastinum – in children and people aged between 19 and 39 (48.2%).
Conclusions: Children develop only aggressive NHL forms, these forms also predominate in adults.  Aggressive NHLs in adults have been most often 
diagnosed in the patients having the primary tumor focus location in the mediastinal and abdominal lymph nodes.  The frequency of indolent NHLs is 
higher in the cases with the primary involvement of the peripheral lymph nodes, the patients’ age being over 60.  Metastases in the bone marrow have 
most frequently been recorded in NHL patients with the primary involvement of peripheral lymph nodes (53.5%).  The involvement of CNS has taken 
place most frequently in the patients with NHLs, having the onset in the abdominal (34.4%) and mediastinal (30.0%) lymph nodes.
Key words: non-Hodgkin’s lymphomas, lymph nodes, age.
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Introduction
Non-Hodgkin’s lymphomas (NHLs) are a heterogenous 
group of malignant tumors, developing from the lymphoid 
tissue and having a wide range of clinical manifestations and 
varied evolution and prognosis.  NHL is one of the most widely 
spread diseases of hemopoietic system.  It represents 4-5% 
in the structure of malignant tumors and has lately shown a 
tendency to grow [1, 2, 3, 4].
The onset of NHLs may occur in any organ or tissue but 
most frequently they primarily develop in the lymph nodes [5, 
6, 7, 8].  There has been an obvious progress in researching the 
NHLs in the recent years with regard to immunology, cytoge-
netics, molecular biology [9, 10, 11, 12, 13, 14].  But only some 
limited researches show that NHL prognosis also depends on 
the location of primary NHLs [15, 16, 17].  These conclusions 
point to the necessity of a differential study of NHLs and an 
obligatory assessment of the disease development regarding 
the NHL primary location.
From the above mentioned it can be concluded that the 
study of NHLs with the involvement of the lymph nodes, 
which are the most frequent primary NHL localizations, is 
clinically actual.
The purpose of this work is to study the frequency and 
clinical peculiarities of NHLs with the primary involvement 
of lymph nodes in respect to patients’ age.
Material and methods
The clinical characteristics have been studied in 228 NHL 
patients with the primary involvement of the lymph nodes, 
their age ranging from 2 to 84 years old.
In all the cases the diagnosis has been confirmed mor-
phologically.
The degree of the tumor process spread in the organism 
has been determined according to the International Clinical 
Classification (ICC) approved in Ann-Arbor, USA in 1971. 
In staging the tumor process and distinguishing the zones of 
initial metastases and in NHL generalization we have used 
the following: clinical, radiologic, ultrasonic examinations, a 
bone marrow puncture, the trepanobiopsy with marrow his-
tological study, the endoscopic and radiologic examinations 
of the gastro-intestinal tract, fibroepipharyngoscopy.
To assess the patients’ survival, the life-table method has 
been used in which the survival limits according to Kaplan-
Meier have been formed.
Results and discussion
The primary involvement of lymph nodes has been de-
tected in 228 out of 606 patients with NHLs, what has made 
up 37.6% (tab. 1).  A higher frequency of NHLs with primary 
involvement of lymph nodes has been observed in children 
(47.1%).  Approximately the same frequency of NHL onset 
in the lymph nodes has been noted in the patients aged 19-39 
and over 60 (38.9% and 39.4% respectively).  Less frequently 
NHLs have had their primary development in the lymph nodes 
in the patients aged between 40 and 59(27.7%).
Table 1
Distribution of NHL patients with primary involvement 
of lymph nodes according to the age
Age
Total 
number
of patients
NHL patients with primary  
involvement of lymph nodes
Absolute number 
of the patients
%
0-18
19-39
40-59
> 60
119
108
181
198
56
42
52
78
47.1
38.9
27.7
39.4
Total 606 228 37.6
Most frequently the peripheral lymph nodes have been 
primarily affected (61.8%), most rarely – the abdominal 
and mediastinal ones (23.3 and 14.9% respectively) (tab. 2). 
However, it should be mentioned that the primary involve-
ment of the abdominal lymph nodes (57.2%) has been pre-
Table 2
Distribution of NHL patients with the primary involvement of lymph nodes according to the  
location of primary tumor focus and age
Location of the primary 
tumor focus
Number of
the pa-
tients
Frequency 
%
Age
0-18
Absolute (%)
19-39
Absolute (%)
40-59
Absolute (%)
> 60
Absolute (%)
Peripheral lymph nodes: 141 61.8 13 (23.3) 26 (61.9) 36 (69.2) 66 (84.6)
Antiauricular 3 1.3 - 2 (4.8) - 1 (1.3)
Submandibular 10 4.3 - 3 (7.1) 1 (1.9) 6 (7.7)
Cervical 70 30.8 12 (21.4) 10 (23.8) 16 (30.8) 32 (41.0)
Supraclavicular 11 4.8 - 1 (2.4) 3 (5.8) 7 (8.9)
Axillary 23 10.1 - 4 (9.5) 11 (21.1) 8 (10.3)
Inguinal 24 10.5 1 (1.8) 6 (14.3) 5 (9.6) 12 (15.4)
Mediastinal lymph nodes  34 14.9 11 (19.6) 12 (28.6) 6 (11.5) 5 (6.4)
Abdominal lymph nodes 53 23.3 32 (57.2) 4 (9.5) 10 (1.9) 7 (9.0)
Total 228 100 56 (100) 42 (100) 52 (100) 78 (100)
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dominant in children, and the peripheral lymph nodes have 
more frequently affected the adults over 60 years old (84.6%). 
NHLs with the onset in the peripheral lymph nodes, both in 
children and adults, most frequently have begun developing 
in the cervical lymph nodes.  NHLs with the onset in the 
mediastinum have been most frequent in children and people 
aged 19-39 (19.6% and 28.6% respectively) (tab. 2).
The above shows that the frequency of different lymph 
nodes involvement is different depending on the age.
The morphological verification of the diagnosis indica-
tes that children have developed only aggressive forms of 
NHLs; these have been also predominating in adults.  Still, it 
can be mentioned that the number of patients with indolent 
NHL forms increases with age.  Indolent NHL forms have 
most frequently occurred in the patients aged over 60 and 
their number has been approximately the same as that of the 
aggressive forms (tab. 3).
Table 3
Distribution of NHL patients with the primary 
involvement of lymph nodes according  to the age and 
morphological variants
Age
Number 
of pa-
tients
Morphological variants
Aggressive
Absolute (%) 
Indolent
Absolute (%)
Unidentified
Absolute (%)
0-18 56 56 (100) - -
19-39 42 33 (78.6) 7 (16.7) 2 (4.7)
40-59 52 30 (57.7) 20 (38.5) 2 (3.8)
> 60 78 37 (47.4) 34 (43.6) 7 (9.0)
Total 228 156 (68.4) 61 (26.8) 11 (4.8)
After studying the frequency of morphological NHL vari-
ants according to the primary tumor focus in the lymph nodes 
we have determined that the aggressive variants predominate 
and do not depend on the primary location.  Most of the 
patients with the primary NHL location in the mediastinal 
and abdominal lymph nodes have developed aggressive NHLs 
(91.3% and 86.8%, respectively).  Indolent NHL frequency has 
been higher in patients with NHLs beginning in the peripheral 
lymph nodes (37.6%) (tab. 4).
Thus, the frequency of aggressive and indolent NHL cases 
varies according to the age and the primary tumor focus locati-
on in different groups of lymph nodes.  Only aggressive NHLs 
have been recorded in children and these have predominated 
in adults as well.  The aggressive NHLs in adults have been 
predominantly diagnosed in the patients having the primary 
tumor focus location in the mediastinal and abdominal lymph 
nodes.  The indolent NHL frequency has been higher in the 
patients over 60 years old and in the cases with the tumor 
primary location in the peripheral lymph nodes.
In accordance with the ICC more than half of the patients 
(61.4%) have been assessed by generalized tumor stages (III 
and IV) which have predominated in children, patients aged 
40-59 and over 60 (60.7%, 71.1% and 68.0% respectively). 
Only in the group of patients aged 19-39 in 61.9% of cases 
NHLs have been diagnosed to be in the local stages of de-
velopment (tab. 5).Most frequently the initial tumor stages 
of development, especially stage I, have been determined in 
NHL patients with primary involvement of the peripheral 
lymph nodes (tab. 6).
The symptoms of general intoxication have been recorded 
in 100 (43.8%) cases.  Frequently the symptoms of general 
intoxication have been present in NHL patients with primary 
Table 4
Distribution of NHL patients with the primary involvement of lymph nodes according to morphological  
variant and primary tumor focus location
Primary tumor focus location
Number of
patients
Morphological variants
Aggressive
Absolute (%)
Indolent
Absolute (%)
Unidentified
Absolute (%)
Peripheral lymph nodes 141 79 (56.0) 53 (37.6) 9 (6.4)
Mediastinal lymph nodes 34 31 (91.3) 2 (5.8) 1 (2.9)
Abdominal lymph nodes 53 46 (86.8) 6 (11.3) 1 (1.9)
Total 228 156 (68.4) 61 (26.8) 11 (4.8)
Table 5
Distribution of NHL patients with the primary involvement of lymph nodes according to the clinical stage and age
Age
Number of the pa-
tients
Clinical stage
I
Absolute (%)
II
Absolute (%)
III
Absolute (%)
IV
Absolute (%)
0-18 56 7 (12.5) 15 (26.8) 9 (16.1) 25 (44.6)
19-39 42 10 (23.8) 16 (38.1) 7 (16.7) 9 (21.4)
40-59 52 8 (15.4) 7 (13.5) 10 (19.2) 27 (51.9)
> 60 78 9 (11.5) 16 (20.5) 18 (23.1) 35 (44.9)
Total 228 34 (14.9) 54 (23.7) 44 (19.3) 96 (42.1)
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involvement of mediastinal (91.2%) and abdominal (70.4%) 
lymph nodes.  Less frequently the general intoxication symp-
toms have been recorded in the patients with NHL primary 
focus in the peripheral lymph nodes (21.9%).  The character of 
the intoxication symptoms has been different; NHL cases with 
the primary involvement of mediastinal and peripheral lymph 
nodes have been predominantly accompanied by fever, while 
for the patients with NHLs, having their onset in the abdomi-
nal lymph nodes, the loss of weight has been characteristic.
Regardless of the location of the primary tumor focus and 
the patients’ age, in most of the cases (72.1%), NHLs have been 
spread onto the sentinel lymph nodes and subsequently onto 
the more distant ones.
Extra nodal foci have developed in liver (42.6%), bone 
marrow (39.3%), spleen (28.2%), central nervous system 
(CNS) (17.9%), soft tissue (17.2%), pulmonary tissue (12.4%) 
and pleura (14.5%).  Only rarely other organs and tissues have 
been involved in the process of generalization.
The frequency of metastases in the liver, spleen, soft tissue, 
pulmonary tissue and other organs and tissues has been low 
and has not correlated with the NHL primary focus location 
and the patients’ age, while the involvement of bone marrow 
and CNS in the process of NHL generalization has varied 
according to the tumor primary focus location, the morpho-
logical variant and the age.
The involvement of bone marrow has been diagnosed 
more frequently in the patients with NHL onset in the periph-
eral lymph nodes (53.5%) and has been established in all age 
groups, predominating in the group of patients aged between 
40 and 59 (65.2%) and in indolent NHL cases (77.3%).  In 
NHL cases with primary involvement of the abdominal and 
mediastinal lymph nodes the bone marrow has been less often 
affected and has constituted 39.3% and 30.0% respectively.
In mediastinal NHLs the metastases in the bone marrow 
have developed in the patients under 40, primarily in children 
(63.7%) in the NHL aggressive variants.  In NHL patients with 
primary involvement of the abdominal lymph nodes the bone 
marrow has been predominantly affected in patients over 
50 years old (71.4%) and only in the indolent NHL variants.
The involvement of the CNS has most frequently devel-
oped in NHLs with the primary involvement of abdominal 
(34.4%) and mediastinal (30.0%) lymph nodes.  Very rarely 
the metastases in the CNS have been recorded in the patients 
with NHL onset in the peripheral lymph nodes (2.8%) and 
only in children – in 50.0% of cases.  The CNS involvement 
has not been recorded in the above group of adult patients.
In NHL patients with the primary involvement of the 
abdominal and mediastinal lymph nodes the metastases in 
the CNS have predominantly developed in children (90.9% 
and 54.5% respectively).
In the NHL adults with the primary involvement of the 
abdominal lymph nodes the metastases in the CNS have 
occurred very rarely, only in one patient aged 29 (4.7%).  In 
mediastinal NHLs the involvement of the CNS has been re-
corded in 25.0% of patients aged up to 40.
From the above it can be concluded that the prevention 
of CNS involvement should be carried out not only in all 
the children with NHL onset in the lymph nodes, no matter 
where the location of the primary tumor focus is, but also in 
the adults under 40 years old with mediastinal NHLs.
The general survival period of more than 5 years in 
patients with the primary involvement of lymph nodes has 
been 36.9% of cases.  The survival figures have been higher 
in the patients with the primary involvement of the periph-
eral lymph nodes (46.8%), being followed by those referring 
to the patients having NHL onset in the abdominal lymph 
nodes (36.4%).  In the patients with mediastinal NHLs the 
general survival period of 5 years has been very rare and has 
constituted only 5.8%.
These data indicate an aggressive NHL evolution in the 
cases with the primary involvement of mediastinal lymph 
nodes.
The emphasized clinical peculiarities of NHLs with the 
primary involvement of lymph nodes will enrich the general 
knowledge about this disease and will contribute to the opti-
mization of the diagnosis and treatment conduct.
Conclusions
1. The frequency of NHLs with the primary involvement 
of lymph nodes is 37.6%.
2. Most frequently NHLs primarily develop in the periphe-
ral lymph nodes (61.8%), less frequently – in the abdominal 
(23.3%) and mediastinal (14.9%) lymph nodes.
3. NHL onset in the peripheral lymph nodes most 
frequently occur in the patients over 60 years old (84.6%), 
Table 6
Distribution of NHL patients with the primary involvement of lymph nodes according to the clinical  
stage and primary focus location
Primary tumor focus 
location
Number of
patients
Clinical stage
I
Absolute (%)
II
Absolute (%)
III
Absolute (%)
IV
Absolute (%)
Lymph nodes:
Peripheral 141 29 (20.6) 30 (21.2) 29 (20.6) 53 (37.6)
Mediastinal 34 1 (2.9) 9 (26.5) 4 (11.8) 20 (58.8)
Abdominal 53 4 (7.5) 15 (28.3) 11 (20.8) 23 (43.4)
Total 228 34 (14.9) 54 (23.7) 44 (19.3) 96 (42.1)
RESEARCH STUDIES , February 2014, Vol. 57, No 1
13
in the abdominal lymph nodes – in children (57.2%), in the 
mediastinum – in children and patients aged 19-39 (48.2%).
4. Children develop only aggressive NHL variants, which 
also predominate in adults. Aggressive NHLs in adults have 
been predominantly diagnosed in the patients having the pri-
mary tumor focus location in the abdominal and mediastinal 
lymph nodes.  The indolent NHL frequency has been higher 
in case of primary involvement of peripheral lymph nodes in 
patients aged over 60.
5. The frequency of metastases in the bone marrow and 
CNS has been dependent on the location of NHL primary 
focus, morphological variant and age.
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Abstract
Background:  The characteristics of visual evoked potentials (VEP) have been studied in diabetic patients with and without diabetic retinopathy.
Material and methods: The magnetic impulses (2.0 Tl at the height of impulse) have been delivered to the cerebellar surface trans-cranially, using 
Neuro-MS/D, (Russian Federation), and the VEP have been registered every 20 seconds from the moment of the photo stress during one minute.
Results: An increase of the latency period and a reduction of the VEP amplitude have been recorded in the period following the exposure of the macular 
part of the retina to the photo stress.  The VEP characteristics have been restored to the initial level at 74.3 + 3.1 seconds from the photo stress moment 
in the control group, while in the diabetic patients with and without retinopathy this index has been 131.7 + 10.2 and 86.5 + 5.5 seconds respectively. 
In the presence of cerebellar trans-cranial magnetic stimulations (2.0 Тl, 40 impulses) the VEP amplitude depression has been less pronounced, and the 
restoration period of the VEP characteristics shortened to 90.5 + 6.8 seconds in the patients with diabetic retinopathy.
Conclusions: 1. Retinopathy development is linked to a prolonged VEP latency period (P100), lowering N75-P100 amplitude, as well as to the 
enlargement of the recovery period of the retina’s functional capacity in patients suffering from the diabetes mellitus in the presence of photo stress.  2. 
The cerebellar trans-cranial magnetic stimulation facilitates a quicker recovery of the retina’s functional capacity in response to the photo stress in the 
diabetic patients with retinopathy.  3. The periodical cerebellar trans-cranial stimulations may be considered as a prevention method as well as a treatment 
method of diabetic retinopathy.
Key words: diabetic retinopathy, visual evoked potential, trans-cranial magnetic stimulation.
